Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances TEMP - Oncology Nurse Advisor
Oncology Data Advisor - Management of Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors
Chronic Myeloid Leukemia: Part I—Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States | Published in Journal of Health Economics and Outcomes Research
Monitoring of molecular response in CML by RQ PCR. Hierarchic order of... | Download Scientific Diagram
Bio-Rad Launches Digital PCR Test for Monitoring Chronic Myeloid Leukemia Response to Therapy | Clinical Lab Products
Why is it critical to achieve a deep molecular response in chronic myeloid leukemia? | Haematologica
Chronic Myeloid Leukemia (CML) lab tests and monitoring
Chronic Myeloid Leukemia (CML) – Cancer Genetics and Genomics Laboratory
New approaches to molecular monitoring in CML (and other diseases) - ScienceDirect